Development and validation of a genomic surveillance workflow for antimicrobial resistance in aquaculture pathogens

Active Cooperative Agreement Awarded

Award ID
U18FD008946
Recipient
Awarding agency
Obligated
$100,000

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 16% complete
Funding agency
Food and Drug Administration Department of Health and Human Services
Place of performance
Blacksburg, VA 24061, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services Food and Drug Administration awarded Cooperative Agreement U18FD008946 to Virginia Polytechnic Institute & State University (Virginia Tech), with $100,000 obligated, on September 23, 2026, under the Food and Drug Administration Research program (CFDA 93.103). The recipient will develop and validate a genomic surveillance workflow for antimicrobial resistance in aquaculture pathogens. Aim 1 characterizes antimicrobial resistance phenotypes and genotypes in 800 isolates, including whole-genome sequencing of a targeted subset of 400, to define temporal and ecological resistance patterns and identify priority resistance determinants. Aim 2 develops and performs early validation of molecular detection tools for those determinants using a staged singleplex-to-multiplex PCR approach, with analytical validation in cultured isolates and representative aquaculture matrices. The work draws on a longitudinal biobank of aquaculture-associated bacterial isolates spanning over four decades. Target pathogens include species within the genera Aeromonas, Edwardsiella, Flavobacterium, Vibrio, and Streptococcus. The period of performance runs from the award date through September 30, 2027, with place of performance in Blacksburg, Virginia 24061.

Description

Abstract
Antimicrobial resistance (AMR) in aquaculture systems is an emerging threat at the intersection of animal health, environmental microbiology, and food safety. Intensive production environments promote high-density microbial populations, antimicrobial exposure, and horizontal gene transfer, facilitating the emergence and persistence of resistance determinants. Major aquaculture pathogens, including species within the genera aeromonas, edwardsiella, flavobacterium, vibrio, and streptococcus, are increasingly associated with multidrug resistance; however, there remains no standardized framework for defining AMR trends over time or translating genomic data into practical surveillance tools for aquaculture systems. This project is enabled by a large, longitudinal biobank of aquaculture-associated bacterial isolates spanning over four decades, combined with an established diagnostic and aquaculture network across virginia, the mid- atlantic, and national collaborators. The central hypothesis is that longitudinal genomic analysis of archived and contemporary isolates will identify conserved and emerging resistance determinants that can be translated into a targeted molecular surveillance framework for early detection of AMR risks. To test this hypothesis, aim 1 will characterize antimicrobial resistance phenotypes and genotypes in 800 isolates, including whole-genome sequencing of a targeted subset of 400 isolates, to define temporal and ecological patterns of resistance and identify priority resistance determinants. Aim 2 will develop and perform early validation of molecular tools for detection of these determinants using a staged singleplex-to-multiplex PCR approach, with analytical validation in cultured isolates and representative aquaculture matrices. The expected outcomes are a comprehensive, time-resolved dataset linking resistance phenotypes to genomic determinants and a set of validated molecular targets for AMR detection. This project will establish a scalable framework for AMR surveillance in aquaculture systems, enabling earlier detection of resistance trends, improving antimicrobial stewardship, and supporting one health efforts to mitigate the spread of AMR across animal, environmental, and human systems.

Quick answers

Who received award U18FD008946?

U18FD008946 was awarded to Virginia Polytechnic Institute & State University by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008946 worth?

$100,000 has been obligated on U18FD008946.

Which agency awarded U18FD008946?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008946, with funding from Food and Drug Administration (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award